ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 738

$933K Total Retail Price of All Prescriptions

Rank: 33 out of 738

588 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 588 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

7% of this provider’s 2,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
BENZTROPINE MESYLATE 609 132 R 1 6
RISPERIDONE 536 177 2 2
ZOLPIDEM TARTRATE 448 169 3 3
FLUOXETINE HCL 373 109 4 8
TRAZODONE HCL 367 65 5 1
CITALOPRAM HBR 345 121 6 4
SERTRALINE HCL 344 127 7 5
QUETIAPINE FUMARATE 338 114 8 9
BUPROPION HCL SR 320 56 9 22
MIRTAZAPINE 294 142 10 10
DIVALPROEX SODIUM ER 280 55 11 24
LITHIUM CARBONATE 218 0 12 25
BUSPIRONE HCL 213 23 13 20
LAMOTRIGINE 206 62 14 12
ABILIFY 183 37 15 7
OLANZAPINE 181 23 16 18
DONEPEZIL HCL 174 154 17 21
ZIPRASIDONE HCL 170 24 18 36
PAROXETINE HCL 168 70 19 16
HALOPERIDOL 162 20 20 29
NAMENDA 162 155 20 26
ALPRAZOLAM 153 0 22 17
CYMBALTA 148 39 23 11
AMPHETAMINE SALT COMBO 147 25 S2 24 37
DIVALPROEX SODIUM 145 75 25 23
VENLAFAXINE HCL ER 131 22 26 19
HYDROXYZINE PAMOATE 130 18 R 27 32
SEROQUEL 118 32 28 27
SEROQUEL XR 115 45 29 13
ESCITALOPRAM OXALATE 109 48 30 14
GABAPENTIN 104 23 31 33
OXCARBAZEPINE 102 0 32 44
RISPERIDONE ODT 92 46 10 33 140
AMITRIPTYLINE HCL 75 13 R 34 47
LORAZEPAM 72 22 35 34
VENLAFAXINE HCL 72 20 35 40
METHYLPHENIDATE HCL 70 0 37 63
GEODON 60 0 38 65
TOPIRAMATE 53 0 39 39
CARISOPRODOL 53 0 R 39 75
NALTREXONE HCL 51 0 41 136
LEXAPRO 50 24 42 35
ZYPREXA 50 12 42 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.